SAMN45062340
External Id
dbGaP
INSDC center name
2024-11-26T12:10:22.957Z
INSDC first public
2024-12-06T05:41:25.087Z
INSDC last update
SRS23424730
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS23424730
SRA accession
DNA
analyte type
NCI_AtezolizumabChemoradiotherapyCervicalCancer
biospecimen repository
GADISP_FP02_TCRB
biospecimen repository sample id
CERVIX
body site
phs003833
gap_accession
7029024
gap_sample_id
5302181
gap_subject_id
Squamous cell carcinoma
histological type
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
female
sex
Clinical Trial
study design
Uterine Cervical Neoplasms
study disease
NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune System Activation in Patients with Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
study name
Yes
subject is affected
GADISP_FP02_TCRB
submitted sample id
GADISP
submitted subject id
NCI_AtezolizumabChemoradiotherapyCervicalCancer
submitter handle
Uterine Cervical Neoplasms tumor DNA sample from CERVIX of a human female participant in the dbGaP study "NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune System Activation in Patients with Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer"
title